Abstract:Pseudobulbar affect (PBA) is a behavioral syndrome associated with various neurological conditions that typically manifests as uncontrollable laughing or crying. PBA can significantly impact the quality of life of patients affected as these spells can be inappropriate to the social setting or incompatible with the patient's emotional state. The underlying mechanism of PBA appears to be associated with disinhibition in neuronal pathways involving dopamine, serotonin, and glutamate, but the exact mechanism remai… Show more
“…Furthermore, evidence suggests that abnormal dopaminergic, glutamatergic, and serotonergic neurotransmission may also play a role in the development of PBA [1]. Recent neuroimaging studies have demonstrated a reduction in dopamine and serotonin expression, along with increased glutamate neurotransmission within the corticopontine-cerebellar pathways [9]. It is suggested that treatment approaches may involve increasing dopamine and serotonin levels while reducing glutamate neurotransmission [9].…”
Pseudobulbar affect (PBA) is a neurological condition characterized by recurrent, inappropriate, and involuntary outbursts of emotion, primarily crying and laughter, which are dissociated from the individual's emotional experience. The precise underlying cause of PBA remains unknown; however, existing evidence suggests the involvement of dopaminergic, serotonergic, and glutamatergic neurotransmission within the corticopontine-cerebellar pathways responsible for regulating the motor expression of emotions. Additionally, PBA has been observed to co-occur with other neurocognitive and psychiatric disorders. Therefore, it is crucial to consider the possibility of a PBA diagnosis in patients with underlying neurological damage and disorders.
“…Furthermore, evidence suggests that abnormal dopaminergic, glutamatergic, and serotonergic neurotransmission may also play a role in the development of PBA [1]. Recent neuroimaging studies have demonstrated a reduction in dopamine and serotonin expression, along with increased glutamate neurotransmission within the corticopontine-cerebellar pathways [9]. It is suggested that treatment approaches may involve increasing dopamine and serotonin levels while reducing glutamate neurotransmission [9].…”
Pseudobulbar affect (PBA) is a neurological condition characterized by recurrent, inappropriate, and involuntary outbursts of emotion, primarily crying and laughter, which are dissociated from the individual's emotional experience. The precise underlying cause of PBA remains unknown; however, existing evidence suggests the involvement of dopaminergic, serotonergic, and glutamatergic neurotransmission within the corticopontine-cerebellar pathways responsible for regulating the motor expression of emotions. Additionally, PBA has been observed to co-occur with other neurocognitive and psychiatric disorders. Therefore, it is crucial to consider the possibility of a PBA diagnosis in patients with underlying neurological damage and disorders.
“…Imaging studies have shown a reduction in dopamine and serotonin neurotransmission and an increase in glutamate neurotransmission. Therefore, treatment entails increasing dopamine and serotonin neurotransmission and reducing glutamate neurotransmission [7].…”
Pseudobulbar affect (PBA) is a neurological condition that is associated with short periods of involuntary, sudden, and inappropriate emotions such as crying or laughing, which are mood incongruent. An accurate estimate of the prevalence of PBA is hard to obtain due to varying diagnostic criteria and variable patient populations. The cause of PBA is not known, but current evidence suggests dual etiology. A neural circuit dysfunction and an abnormality of neurotransmitters that regulate motor expression of emotions. PBA can easily be mistaken for a depressive disorder due to the overlap of symptoms. Moreover, patients with PBA may have a major depressive disorder (MDD) or other depressive disorders. Therefore, it is essential to recognize and treat PBA as well as possible psychiatric comorbidities. We present a case report of a 59-yearold man with no past psychiatric history who presents with paroxysms of episodes of crying for the past one year. He endorsed feelings of hopelessness and poor concentration. MRI of the brain revealed bilateral basal ganglia and a thalamic infarct. The patient was treated with citalopram. This case describes a unique presentation of pseudobulbar affect mimicking depression.
“…Delirium is a disturbance of consciousness, and this patient does not fall into this category because he had not demonstrated a decreased level of consciousness. PBA is a behavioral syndrome associated with various neurological conditions that typically manifests as uncontrollable laughing or crying (Espiridion et al, 2020). This patient is not considered to have PBA because, although he had emotional upsets, he did not laugh or cry nonstop.…”
The pandemic of coronavirus infection 2019 (COVID-19) is stressing people's daily lives and making them more susceptible to various mental illnesses. Depression and suicide attempt as well as, strangely enough, manic patients are on the rise. The main complication of COVID-19 infection is ischemic stroke. Multiple lacunar infarcts in the white matter of the right middle cerebral artery region induce an imbalance of blood flow in the left and right cerebral cortex and risk causing mania. The increase in mania during the COVID-19 must be considered not only a primary increase due to stress but also poststroke mania secondary to COVID-19 infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.